Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 3 (2006), Issue 5 (May)

1. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial.
   Br J Psychiatry, 188: 439-48. [Abstract] [Full-text]
2. Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol.
   J Pharm Sci, 95(6): 1308-17. [Abstract] [Full-text]
3. Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence.
   J Consult Clin Psychol, 74(2): 307-16. [Abstract] [Full-text]
4. Mediators of the Stress-Substance-Use Relationship in Urban Male Adolescents.
   Prev Sci. [Abstract] [Full-text]
5. Declared and undeclared substance use among emergency department patients: a population-based study.
   Addiction, 101(5): 706-12. [Abstract] [Full-text]
6. Changes in cannabis use and its consequences over 3 years in a remote indigenous population in northern Australia.
   Addiction, 101(5): 696-705. [Abstract] [Full-text]
7. Two brain sites for cannabinoid reward.
   J Neurosci, 26(18): 4901-7. [Abstract] [Full-text]
8. Hepatitis C virus infection among homeless men referred from a community clinic.
   West J Nurs Res, 28(4): 475-88. [Abstract] [Full-text]
9. Co-distribution of the cannabinoid CB1 receptor and the 5-HT transporter in the rat amygdale.
   Eur J Pharmacol, 537(1): 70-1. [Abstract] [Full-text]
10. Characterization of the drug-positive adolescent trauma population: should we, do we, and does it make a difference if we test?
    J Pediatr Surg, 41(5): 927-30. [Abstract] [Full-text]
11. Coma due to cannabis toxicity in an infant.
    Eur J Emerg Med, 13(3): 177-9. [Abstract] [Full-text]
12. Cannabinoids and prefrontal cortical function: Insights from preclinical studies.
    Neurosci Biobehav Rev, 30(5): 680-95. [Abstract] [Full-text]
13. The Marijuana Ladder: measuring motivation to change marijuana use in incarcerated adolescents.
    Drug Alcohol Depend, 83(1): 42-8. [Abstract] [Full-text]
14. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.
    Drug Alcohol Depend, 83(1): 90-3. [Abstract] [Full-text]
15. Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo.
    Am J Physiol Lung Cell Mol Physiol, 290(6): L1202-9. [Abstract] [Full-text]
16. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use.
    Harm Reduct J, 3(1): 17. [Abstract] [Full-text]
17. Oral lesions of 500 habitual psychoactive substance users in Chennai, India.
    Arch Oral Biol, 51(6): 512-9. [Abstract] [Full-text]
18. Cannabinoids and cancer: pros and cons of an antitumour strategy.
    Br J Pharmacol, 148(2): 123-35. [Abstract] [Full-text]
19. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
    Neurosci Lett, 400(3): 262-6. [Abstract] [Full-text]
20. Implication of Cannabinoids in Neurological Diseases.
    Cell Mol Neurobiol. [Abstract] [Full-text]
21. Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors.
    J Am Coll Cardiol, 47(10): 1919-26. [Abstract] [Full-text]
22. The use of record linkage to examine illicit drug use in pregnancy.
    Addiction, 101(6): 873-82. [Abstract] [Full-text]
23. Violent victimization and drug involvement among Mexican middle school students.
    Addiction, 101(6): 850-6. [Abstract] [Full-text]
24. The genetic epidemiology of cannabis use, abuse and dependence.
    Addiction, 101(6): 801-12. [Abstract] [Full-text]
25. Development and validation of a method for the quantitation of Delta9 tetrahydrocannabinol in human plasma by high performance liquid chromatography after solid-phase extraction.
    J Pharm Biomed Anal, 41(3): 1011-6. [Abstract] [Full-text]
26. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
    Psychopharmacology (Berl), 186(2): 226-34. [Abstract] [Full-text]
27. Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment.
    Int J Neuropsychopharmacol, 9(3): 277-86. [Abstract] [Full-text]
28. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons.
    Eur J Neurosci, 23(9): 2385-94. [Abstract] [Full-text]
29. DNA polymorphisms in the tetrahydrocannabinolic acid (THCA) synthase gene in "drug-type" and "fiber-type" Cannabis sativa L.
    Forensic Sci Int, 159(2): 132-40. [Abstract] [Full-text]
30. {Delta}9-Tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription.
    Mol Hum Reprod, 12(5): 321-333. [Abstract] [Full-text]
31. Young adult smoker risk perceptions of traditional cigarettes and nontraditional tobacco products.
    Am J Health Behav, 30(3): 302-12. [Abstract] [Full-text]
32. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness.
    J Subst Abuse Treat, 30(4): 291-5. [Abstract] [Full-text]
33. American Indian adolescents in substance abuse treatment: diagnostic status.
    J Subst Abuse Treat, 30(4): 275-84. [Abstract] [Full-text]
34. Differential effects of delta(9)-THC on learning in adolescent and adult rats.
    Pharmacol Biochem Behav, 83(3): 448-55. [Abstract] [Full-text]
35. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
    Neuropharmacology, 50(7): 788-806. [Abstract] [Full-text]
36. Different lengths of times for progressions in adolescent substance involvement.
    Addict Behav, 31(6): 962-83. [Abstract] [Full-text]
37. Using the brain P300 response to identify novel phenotypes reflecting genetic vulnerability for adolescent substance misuse.
    Addict Behav, 31(6): 1067-87. [Abstract] [Full-text]
38. Duration of cannabis use - a novel phenotype?
    Addict Behav, 31(6): 984-94. [Abstract] [Full-text]
39. Is there heterogeneity among syndromes of substance use disorder for illicit drugs?
    Addict Behav, 31(6): 929-47. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.